Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$865M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$842M |
| 3 |
Direxion Daily 20+ Year Treasury Bull 3X Shares
TMF
|
+$787M |
| 4 |
iShares MSCI India ETF
INDA
|
+$760M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$725M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.17B |
| 3 |
Microsoft
MSFT
|
+$2.16B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Netflix
NFLX
|
+$865M |
Sector Composition
| 1 | Technology | 14.92% |
| 2 | Consumer Discretionary | 7.06% |
| 3 | Financials | 6.33% |
| 4 | Healthcare | 4.61% |
| 5 | Industrials | 4.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FLG
1026
Flagstar Financial, Inc.
FLG
$5.27B
| $7.02M | ﹤0.01% |
726,655
+519,637
| +251% | +$5.02M |
|
1027
MarketAxess Holdings
MKTX
$6.91B
| $7M | ﹤0.01% |
31,932
-13,671
| -30% | -$3M |
|
1028
Brown-Forman Class B
BF.B
$13B
| $6.99M | ﹤0.01% |
135,384
+27,663
| +26% | +$1.43M |
|
1029
Black Hills Corp
BKH
$4.33B
| $6.98M | ﹤0.01% |
127,845
+63,687
| +99% | +$3.48M |
|
1030
EPAM Systems
EPAM
$8.69B
| $6.96M | ﹤0.01% |
25,206
+4,914
| +24% | +$1.36M |
|
1031
Acadia Pharmaceuticals
ACAD
$3.98B
| $6.95M | ﹤0.01% |
376,061
-70,256
| -16% | -$1.3M |
|
1032
iShares iBonds Dec 2025 Term Muni Bond ETF
IBMN
$415M
| $6.92M | ﹤0.01% |
261,645
-951,093
| -78% | -$25.2M |
|
1033
Moelis & Co
MC
$5.54B
| $6.92M | ﹤0.01% |
121,916
+50,667
| +71% | +$2.88M |
|
1034
Exelixis
EXEL
$10.5B
| $6.92M | ﹤0.01% |
291,448
-14,233
| -5% | -$338K |
|
1035
Schwab Fundamental International Small Company Index ETF
FNDC
$3.03B
| $6.91M | ﹤0.01% |
194,828
-1,359,866
| -87% | -$48.2M |
|
1036
Dimensional International Core Equity 2 ETF
DFIC
$10.4B
| $6.91M | ﹤0.01% |
258,307
-4,987,905
| -95% | -$133M |
|
1037
BondBloxx Bloomberg Six Month Target Duration US Treasury ETF
XHLF
$1.97B
| $6.91M | ﹤0.01% |
137,304
+110,494
| +412% | +$5.56M |
|
|
AUNA
1038
Auna
AUNA
$469M
| $6.9M | ﹤0.01% |
+647,800
| New | +$6.9M |
|
1039
Invesco BulletShares 2028 High Yield Corporate Bond ETF
BSJS
$459M
| $6.9M | ﹤0.01% |
318,513
+227,711
| +251% | +$4.93M |
|
1040
iShares Interest Rate Hedged Corporate Bond ETF
LQDH
$507M
| $6.9M | ﹤0.01% |
73,342
-21,253
| -22% | -$2M |
|
1041
Werner Enterprises
WERN
$1.68B
| $6.89M | ﹤0.01% |
176,164
+83,819
| +91% | +$3.28M |
|
1042
PVH
PVH
$3.9B
| $6.88M | ﹤0.01% |
48,911
-35,493
| -42% | -$4.99M |
|
1043
Workiva
WK
$4.34B
| $6.84M | ﹤0.01% |
80,703
-6,197
| -7% | -$526K |
|
|
EXE
1044
Expand Energy Corporation Common Stock
EXE
$22.9B
| $6.84M | ﹤0.01% |
77,035
-115,677
| -60% | -$10.3M |
|
1045
Lincoln Electric
LECO
$13.2B
| $6.84M | ﹤0.01% |
26,764
+9,164
| +52% | +$2.34M |
|
1046
Amkor Technology
AMKR
$6.29B
| $6.81M | ﹤0.01% |
211,207
+34,164
| +19% | +$1.1M |
|
1047
FT Vest Fund of Buffer ETFs
BUFR
$7.4B
| $6.77M | ﹤0.01% |
242,290
+193,828
| +400% | +$5.42M |
|
1048
Modine Manufacturing
MOD
$7.86B
| $6.75M | ﹤0.01% |
70,920
-24,123
| -25% | -$2.3M |
|
1049
Repligen
RGEN
$6.39B
| $6.75M | ﹤0.01% |
36,690
-5,366
| -13% | -$987K |
|
1050
Madrigal Pharmaceuticals
MDGL
$9.63B
| $6.72M | ﹤0.01% |
25,151
-191,667
| -88% | -$51.2M |
|